Lanzone, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 13.760
EU - Europa 11.315
AS - Asia 10.454
SA - Sud America 1.978
AF - Africa 302
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 9
Totale 37.855
Nazione #
US - Stati Uniti d'America 13.387
SG - Singapore 5.007
DE - Germania 3.095
CN - Cina 2.115
BR - Brasile 1.586
SE - Svezia 1.493
PL - Polonia 1.422
IT - Italia 1.244
VN - Vietnam 1.185
FR - Francia 967
UA - Ucraina 661
GB - Regno Unito 603
IE - Irlanda 422
NL - Olanda 419
IN - India 381
FI - Finlandia 318
ID - Indonesia 301
JP - Giappone 284
HK - Hong Kong 241
RU - Federazione Russa 210
CA - Canada 177
TR - Turchia 170
AR - Argentina 155
BD - Bangladesh 139
MX - Messico 109
IQ - Iraq 102
BE - Belgio 93
AT - Austria 71
ZA - Sudafrica 70
PK - Pakistan 67
EC - Ecuador 62
ES - Italia 55
IR - Iran 55
CI - Costa d'Avorio 52
KR - Corea 51
CO - Colombia 45
PH - Filippine 42
VE - Venezuela 42
CZ - Repubblica Ceca 40
MA - Marocco 40
UZ - Uzbekistan 36
SA - Arabia Saudita 33
LT - Lituania 32
AE - Emirati Arabi Uniti 31
JO - Giordania 30
CH - Svizzera 29
EG - Egitto 29
KE - Kenya 27
AU - Australia 25
CL - Cile 25
AZ - Azerbaigian 21
IL - Israele 20
NP - Nepal 19
RO - Romania 19
PE - Perù 18
PY - Paraguay 17
ET - Etiopia 16
MY - Malesia 16
PT - Portogallo 16
DO - Repubblica Dominicana 15
UY - Uruguay 15
DZ - Algeria 14
LV - Lettonia 14
NO - Norvegia 14
JM - Giamaica 13
BG - Bulgaria 12
KZ - Kazakistan 11
NZ - Nuova Zelanda 11
PA - Panama 11
TH - Thailandia 11
TN - Tunisia 11
CR - Costa Rica 10
AL - Albania 9
BO - Bolivia 9
PS - Palestinian Territory 9
HN - Honduras 7
HR - Croazia 7
KG - Kirghizistan 7
LK - Sri Lanka 7
RS - Serbia 7
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
AO - Angola 6
GE - Georgia 6
GR - Grecia 6
HU - Ungheria 6
LB - Libano 6
NG - Nigeria 6
NI - Nicaragua 6
OM - Oman 6
BB - Barbados 5
BY - Bielorussia 5
GA - Gabon 5
KH - Cambogia 5
KW - Kuwait 5
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
MD - Moldavia 5
SN - Senegal 5
CG - Congo 4
Totale 37.772
Città #
Singapore 2.915
Chandler 1.941
Ashburn 1.376
Warsaw 1.363
San Jose 1.359
Beijing 460
Dallas 436
New York 419
Dublin 416
Ho Chi Minh City 385
Jacksonville 385
Amsterdam 369
San Mateo 362
Los Angeles 350
Hanoi 293
Fairfield 283
Jakarta 262
Lauterbourg 258
Tokyo 258
Wilmington 255
Munich 228
Rome 225
Milan 224
The Dalles 215
Hefei 210
Boston 202
Frankfurt am Main 200
Hong Kong 199
Ann Arbor 194
Houston 191
Woodbridge 183
Nanjing 178
Marseille 174
Nürnberg 174
Seattle 174
Dearborn 168
Princeton 143
São Paulo 136
Helsinki 120
Lancaster 119
Cambridge 115
Cattolica 114
Bremen 113
Council Bluffs 109
Moscow 107
Chicago 100
Brussels 87
Izmir 87
Santa Clara 83
Buffalo 81
Redwood City 80
Lawrence 77
London 74
Da Nang 70
Nanchang 68
Düsseldorf 60
Paris 60
Montreal 59
Mountain View 59
Rio de Janeiro 58
Atlanta 56
Denver 56
Nuremberg 56
University Park 56
Orem 55
Chennai 54
Shanghai 53
Augusta 52
Kent 52
Abidjan 50
Shenyang 50
Brooklyn 47
Zhengzhou 47
Leawood 46
Toronto 46
Johannesburg 45
Seoul 45
Hebei 44
Mexico City 43
Phoenix 43
Turku 43
Vienna 43
Baghdad 40
Haiphong 40
Boardman 39
Norwalk 39
Pune 39
Tianjin 39
San Francisco 38
Belo Horizonte 37
Fremont 37
Redmond 37
Guangzhou 33
Dhaka 32
Hangzhou 32
Stockholm 32
Poplar 29
St Louis 29
Tashkent 29
Lappeenranta 28
Totale 21.174
Nome #
Effect of human chorionic gonadotropin administration on pituitary and luteal response to gonadotropin-releasing hormone 407
A Network Analysis of Perinatal Depression, Anxiety, and Temperaments in Women in the First, Second, and Third Trimesters of Pregnancy 382
In vitro human growth hormone increases human chorionic gonadotropin and progesterone secretion by human placenta at term: evidence of a modulatory role by opioids 333
Indomethacin in vivo inhibits the enhancement of the progesterone secretion in response to gonadotrophin-releasing hormone by human corpus luteum 323
Effect of activin-A on progesterone synthesis in human luteal cells 315
Effect of activin-A on progesterone synthesis in human luteal cells 315
Human growth hormone enhances progesterone production by human luteal cells in vitro. II. Evidence of a distinct effect on two luteal cell types 307
Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone action 306
Insulin secretion in patients with gestational diabetes: relationship with pregnancy outcome 298
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium 294
Insulin plasma levels in pregnant patients with impaired glucose tolerance: relationship with pregnancy outcome 288
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. 279
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease 275
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 248
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 245
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 240
Excretion of SARS-CoV-2 in human breast milk 236
Circulating irisin levels in functional hypothalamic amenorrhea: a new bone damage index? A pilot study. 218
Prenatal diagnosis, natural history, postnatal treatment and outcome of 222 cases of spina bifida: experience of a tertiary center 217
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 210
Assessment of insulin resistance in lean women with polycystic ovary syndrome. 206
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT 204
17β-estradiol protects cerebellar granule cells against β-amyloid-induced toxicity via the apoptotic mitochondrial pathway 201
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 200
Prenatal diagnosis, natural history, postnatal treatment and outcome of 222 cases of spina bifida: experience of a tertiary center 194
The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status 193
Recurrent miscarriage and fetal congenital malformations: Is there a neglected causal association? 192
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 187
L'applicazione del Nuovo Ordinamento del CLM in Medicina e Chirurgia. Le ragioni di un percorso e di una proposta innovativa di Piano di studi nella Facoltà di Medicina e Chirurgia dell'Università Cattolica di Roma 182
Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics 181
L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism 180
The "Preeclampsia and Hypertension Target Treatment" ("PYTT") study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 178
Look at the lung: can chest ultrasonography be useful in pregnancy? 178
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. 177
Adult onset Still's disease and pregnancy 176
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 175
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis 174
Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women. 174
Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? 174
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 172
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples 171
Is there any role for the Hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? 170
The transition from intra to extra-uterine life in late preterm infant: a single-center study 170
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action 170
Persistence of right umbilical vein: A singular case 170
Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings 170
Ovarian Volume And Gluco-Insulinaemic Markers In The Diagnosis Of Pcos During Adolescence 168
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact 168
Is gestational hypertension beneficial in twin pregnancies? 168
Delivery Management in Maternal Varicella Peripartum Infection with Vulvar Lesions: A Case Report 168
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 167
Autoimmunity in obstetrics and autoimmune diseases in pregnancy 167
Knowledge and beliefs about vaccination in pregnant women before and during the COVID-19 pandemic 166
Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study 166
Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women 165
Enhancement of vaccination attitude and flu vaccination coverage among pregnant women attending birthing preparation course 165
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study 164
Carbohydrate metabolism in gestational diabetes: effect of chronic hypertension 163
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 163
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 163
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 161
Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis. 160
Look at the lung: can chest ultrasonography be useful in pregnancy? 159
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study. 159
Prenatal valacyclovir treatment of fetal citomegalovirus infection: A case series 159
The use of different size-hysteroscope in office hysteroscopy: our experience 158
How Metformin Acts in PCOS Pregnant Women: Insights in insulin secretion and peripheral action at each trimester of gestation. 157
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 157
Look at the lung: can chest ultrasonography be useful in pregnancy? 157
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 157
The transition from intra to extra-uterine life in late preterm infant: a single-center study 155
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 154
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study 154
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 152
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 152
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 152
Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. 150
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 150
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study. 150
Epidermal growth factor levels in human breast cyst fluid 149
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study 149
Relationships Between Thyroid Hormones, Insulin-Like Growth Factor-1 and Antioxidant Levels in Hypothalamic Amenorrhea and Impact on Bone Metabolism 149
SARS-CoV-2 Infection in Pregnancy: Clinical Signs, Placental Pathology, and Neonatal Outcome—Implications for Clinical Care 149
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 148
Role of Human Leukocyte Antigens at the Feto-Maternal Interface in Normal and Pathological Pregnancy: An Update. 148
Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women 147
A multi-approach management intervention can lower C-section rate trends: The experience of a Third Level Referral Center de Belvis A.G., Neri C., Angioletti C., Carducci B., Ferrazzani S., Lanzone A., Caruso A. 147
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: Towards specific guidelines and standard operating procedures for the molecular diagnosis 146
Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up 146
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 145
Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? 145
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 144
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 144
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 143
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 143
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 141
Insulin Secretory Patterns and Uteroplacental Doppler Flow Velocimetry in Pregnancies Complicated by Carbohydrate Intolerance: Is There any Relationship? 141
Effects of oral glucose administration on plasma growth hormone levels in women with polycystic ovary syndrome 141
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation 141
Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women 141
Totale 18.776
Categoria #
all - tutte 142.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021343 0 0 0 0 0 0 0 0 0 0 287 56
2021/20222.086 161 138 32 165 79 83 49 382 78 117 340 462
2022/20235.067 644 681 373 811 279 661 280 408 587 92 185 66
2023/20242.463 115 626 70 122 97 437 209 89 43 108 214 333
2024/20255.324 112 146 366 181 520 151 174 265 718 496 1.216 979
2025/202614.606 2.023 466 1.132 1.667 2.737 1.079 2.678 691 1.066 1.010 57 0
Totale 38.330